A major research breakthrough on Parkinson's disease revealed that an already FDA-approved cancer drug could help stem the ...
Researchers from the Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and ...
US-based biotech company Vaxxinity has revealed positive data from part B of its Phase I study with its Parkinson’s vaccine UB-312, demonstrating a 20% reduction in toxic protein levels among ...
Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...
Parkinson’s disease (PD) is characterized by the presence in post-mortem brains of Lewy bodies with aggregated forms of alpha-synuclein (aSyn), a presynaptic protein that exists as both cytosolic and ...
Degeneration of this structure is characteristic of Parkinson's disease. In late 2018, Japanese neurosurgeons at Kyoto University Hospital implanted reprogrammed stem cells into the brain of a ...
Parkinson’s disease (PD) is characterized by the presence in post-mortem brains of Lewy bodies with aggregated forms of alpha-synuclein (aSyn), a presynaptic protein that exists as both cytosolic and ...